VIM and breast cancer: As a therapeutic approach inthis field, microRNA targeting against VIM was shownto decrease breast cancer invasion in animal studies (19).RhoA is another small GTPase with several functions,and it is known to be a key effector in the polymerizationof actin filaments (20).